Skip to main content
. 2024 Jul 21;30(27):3314–3325. doi: 10.3748/wjg.v30.i27.3314

Figure 4.

Figure 4

Receiver operating characteristic of models in training cohort and validation cohort. A: Training cohort; B: Validation cohort. ALBI: Albumin-bilirubin; MELD: Model of end-stage liver disease; PM: Posthepatectomy liver failure model.